<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Bladder Cancer on VitaminDWiki</title><link>/categories/bladder-cancer.html</link><description>Recent content in Bladder Cancer on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Tue, 28 Feb 2017 00:00:00 +0000</lastBuildDate><atom:link href="/categories/bladder-cancer/index.xml" rel="self" type="application/rss+xml"/><item><title>Urinary Bladder Cancer survival is associated with vitamin D receptor: 14 months vs 53 months</title><link>/posts/urinary-bladder-cancer-survival-is-associated-with-vitamin-d-receptor-14-months-vs-53-months.html</link><pubDate>Tue, 28 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/urinary-bladder-cancer-survival-is-associated-with-vitamin-d-receptor-14-months-vs-53-months.html</guid><description/></item><item><title>Bladder cancer modifiable risk factors include low vitamin D – meta-analysis</title><link>/posts/bladder-cancer-modifiable-risk-factors-include-low-vitamin-d-meta-analysis.html</link><pubDate>Thu, 24 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/bladder-cancer-modifiable-risk-factors-include-low-vitamin-d-meta-analysis.html</guid><description/></item><item><title>Bladder cancer 60 percent less likely if have high vitamin D – meta-analysis</title><link>/posts/bladder-cancer-60-percent-less-likely-if-have-high-vitamin-d-meta-analysis.html</link><pubDate>Thu, 24 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/bladder-cancer-60-percent-less-likely-if-have-high-vitamin-d-meta-analysis.html</guid><description/></item><item><title>Poor Bladder Cancer survival associated with poor Vitamin D receptor</title><link>/posts/poor-bladder-cancer-survival-associated-with-poor-vitamin-d-receptor.html</link><pubDate>Sun, 18 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/poor-bladder-cancer-survival-associated-with-poor-vitamin-d-receptor.html</guid><description>&lt;h4 id="expression-of-vitamin-d-receptor-vdr-positively-correlates-with-survival-of-urothelial-bladder-cancer-patients">Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/vdr-bladder-cancer-f2.jpg" alt="image" width="300">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/nds-vs-vdr.jpg" alt="image" width="300">
&lt;p>NDs = Non–classic differentiations&lt;/p>
&lt;p>Int. J. Mol. Sci. 2015, 16, 24369-24386; doi:10.3390/ijms161024369&lt;/p>
&lt;p>Wojciech Jóźwicki 1,2, &lt;a href="mailto:jozwickiw@co.bydgoszcz.pl">jozwickiw@co.bydgoszcz.pl&lt;/a>;, Anna A. Brożyna 1,2, Jerzy Siekiera 3 and Andrzej T. Slominski 4,5&lt;/p>
&lt;p>Department of Tumour Pathology and Pathomorphology, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz 85-796, Poland; E-Mail: &lt;a href="mailto:anna.brozyna@cm.umk.pl">anna.brozyna@cm.umk.pl&lt;/a>&lt;/p>
&lt;p>Department of Tumour Pathology and Pathomorphology, Oncology Centre-Prof. Franciszek Lukaszczyk Memorial Hospital, Bydgoszcz 85-796, Poland&lt;/p></description></item><item><title>Bladder cancer 25 percent less likely if have high vitamin D – meta-analysis</title><link>/posts/bladder-cancer-25-percent-less-likely-if-have-high-vitamin-d-meta-analysis.html</link><pubDate>Sun, 24 May 2015 00:00:00 +0000</pubDate><guid>/posts/bladder-cancer-25-percent-less-likely-if-have-high-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="association-of-vitamin-c-vitamin-d-vitamin-e-and-risk-of-bladder-cancer-a-dose-response-meta-analysis">Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis&lt;/h4>
&lt;p>Scientific Reports 5, Article number: 9599 doi:10.1038/srep09599&lt;/p>
&lt;p>Fuqiang Chen,	Qingshu Li,	Yang Yu,	Wenrong Yang,	Fei Shi	&amp;amp; Yan Qu&lt;/p>
&lt;p>Received 22 September 2014 Accepted 11 March 2015 Published 23 April 2015&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/bladder-cancer.jpg" alt="image" width="500">
&lt;p>A dose-response meta-analysis was conducted to assess the association of vitamin C, D, E with risk of bladder cancer. Pertinent studies were identified in PubMed and Embase. The random-effect model was used. The relative risk (95% confidence interval) of bladder cancer was 0.99 (0.95–1.03) for every 100 IU/day increment in vitamin D from diet plus supplement and &lt;strong>0.95 (0.90–1.00) for every 10 nmol/L increment in circulating vitamin D.&lt;/strong>&lt;/p></description></item><item><title>Off Topic: Cannabinoids as Cancer chemotherapy</title><link>/posts/off-topic-cannabinoids-as-cancer-chemotherapy.html</link><pubDate>Wed, 01 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/off-topic-cannabinoids-as-cancer-chemotherapy.html</guid><description>&lt;h3 id="update-off-topic-cannabis-and-disease-studies-at-greenmedinfo--dec-2015postsoff-topic-cannabis-and-disease-studies-at-greenmedinfo">Update: &lt;a href="/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo">Off topic: Cannabis and disease studies at GreenMedInfo – Dec 2015&lt;/a>&lt;/h3>
&lt;h4 id="the-cannabis-cure-for-cancerhttpwwwgreenmedinfocomblogcannabis-cure-cancer20-greenmedinfo">&lt;a href="http://www.greenmedinfo.com/blog/cannabis-cure-cancer%20">The Cannabis Cure For Cancer&lt;/a> GreenMedInfo&lt;/h4>
&lt;p>Dr. Mark Sircus has also written an ebook: &lt;a href="http://drsircus.com/books/e-book/medical-marijuana/%20">Medical Marijuana&lt;/a> updated April 2014&lt;/p>
&lt;h4 id="summary-of-how-cannabinoids-works">Summary of how Cannabinoids works&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Triggering cell death, through a mechanism called apoptosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Stopping cells from dividing&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Preventing new blood vessels from growing into tumours&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Reducing the chances of cancer cells spreading through the body,&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>by stopping cells from moving or invading neighbouring tissue&lt;/p></description></item><item><title>Molecular Link between Vitamin D and Cancer Prevention</title><link>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</link><pubDate>Wed, 02 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</guid><description>&lt;p>Nutrients 2013, 5(10), 3993-4021; doi:10.3390/nu5103993&lt;/p>
&lt;p>Meis Moukayed 1email and William B. Grant 2,* email&lt;/p>
&lt;p>1 School of Arts and Sciences, American University in Dubai, P. O. Box 28282, Dubai, UAE&lt;/p>
&lt;p>2 Sunlight, Nutrition, and Health Research Center, San Francisco, CA 94164-1603, USA&lt;/p>
&lt;ul>
&lt;li>Author to whom correspondence should be addressed.&lt;/li>
&lt;/ul>
&lt;p>Received: 7 August 2013; in revised form: 11 September 2013 / Accepted: 18 September 2013 / Published: 30 September 2013&lt;/p>
&lt;p>(This article belongs to the Special Issue Vitamin D and Human Health)&lt;/p></description></item><item><title>Higher levels of Vitamin D assocated with bladder cancer survival by veterans</title><link>/posts/higher-levels-of-vitamin-d-assocated-with-bladder-cancer-survival-by-veterans.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/higher-levels-of-vitamin-d-assocated-with-bladder-cancer-survival-by-veterans.html</guid><description>&lt;h3 id="relationship-of-vitamin-d-monitoring-and-status-to-bladder-cancer-survival-in-veterans">Relationship of vitamin D monitoring and status to bladder cancer survival in veterans.&lt;/h3>
&lt;p>South Med J. 2013 Feb;106(2):126-30. &lt;a href="https://doi.org/10.1097/SMJ.0b013e3182824d00.">doi: 10.1097/SMJ.0b013e3182824d00.&lt;/a>&lt;/p>
&lt;p>Peiris AN, Bailey BA, Manning T.&lt;/p>
&lt;p>Department of Internal Medicine, Mountain Home VA Medical Center, Medicine Service-111, Mountain Home, TN 37684, USA. &lt;a href="mailto:peiris@etsu.edu">peiris@etsu.edu&lt;/a>&lt;/p>
&lt;p>OBJECTIVES: Veterans of the armed forces, like most population groups, have a high prevalence of vitamin D deficiency, which may be associated with adverse outcomes in several types of cancer. Ultraviolet irradiation is inversely linked with the risk of bladder cancer, presumably through enhanced vitamin D synthesis. We hypothesized that variations in vitamin D status and monitoring predict adverse outcomes in bladder cancer among veterans.&lt;/p></description></item><item><title>Free vitamin D (VDR) may be more important than total for bladder cancer</title><link>/posts/free-vitamin-d-vdr-may-be-more-important-than-total-for-bladder-cancer.html</link><pubDate>Fri, 22 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/free-vitamin-d-vdr-may-be-more-important-than-total-for-bladder-cancer.html</guid><description>&lt;h4 id="influence-of-vitamin-d-binding-protein-on-the-association-between-circulating-vitamin-d-and-risk-of-bladder-cancer">Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.&lt;/h4>
&lt;p>Br J Cancer. 2012 Oct 23;107(9):1589-94. &lt;a href="https://doi.org/10.1038/bjc.2012.417.">doi: 10.1038/bjc.2012.417.&lt;/a> Epub 2012 Sep 18.&lt;/p>
&lt;p>Mondul AM, Weinstein SJ, Virtamo J, Albanes D.&lt;/p>
&lt;p>Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, 6120 Executive Boulevard, Suite 320, Rockville, MD, USA. &lt;a href="mailto:mondulam@mail.nih.gov">mondulam@mail.nih.gov&lt;/a>&lt;/p>
&lt;p>BACKGROUND: There is little research investigating the role of &lt;strong>vitamin D binding protein (DBP)&lt;/strong> in the association between 25-hydroxyvitamin D (25(OH)D) and disease risk.&lt;/p></description></item><item><title>Hypothesis: Vitamin D or UV will decrease bladder cancer</title><link>/posts/hypothesis-vitamin-d-or-uv-will-decrease-bladder-cancer.html</link><pubDate>Wed, 06 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/hypothesis-vitamin-d-or-uv-will-decrease-bladder-cancer.html</guid><description>&lt;h2 id="relationship-of-vitamin-d-monitoring-and-status-to-bladder-cancer-survival-in-veterans">Relationship of vitamin d monitoring and status to bladder cancer survival in veterans.&lt;/h2>
&lt;p>South Med J. 2013 Feb;106(2):126-30. &lt;a href="https://doi.org/10.1097/SMJ.0b013e3182824d00.">doi: 10.1097/SMJ.0b013e3182824d00.&lt;/a>&lt;/p>
&lt;p>Peiris AN, Bailey BA, Manning T.&lt;/p>
&lt;p>From the Mountain Home VA Medical Center and East Tennessee State University, Mountain Home and Johnson City, Tennessee.&lt;/p>
&lt;p>OBJECTIVES: Veterans of the armed forces, like most population groups, have a high prevalence of vitamin D deficiency, which may be associated with adverse outcomes in several types of cancer. Ultraviolet irradiation is inversely linked with the risk of bladder cancer, presumably through enhanced vitamin D synthesis. We hypothesized that variations in vitamin D status and monitoring predict adverse outcomes in bladder cancer among veterans.&lt;/p></description></item><item><title>Vitamin D and Risk of Rarer Cancers</title><link>/posts/vitamin-d-and-risk-of-rarer-cancers.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-risk-of-rarer-cancers.html</guid><description>&lt;h4 id="shedding-light-on-serum-vitamin-d-concentrations-and-the-risk-of-rarer-cancers">Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers&lt;/h4>
&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.65-69 (5)&lt;/p>
&lt;p>Authors: Kathy J. Helzlsouer, Lisa Gallicchio&lt;/p>
&lt;p>Cancer is a broad term for many disparate diseases with different etiologies, commonly classified by affected organ site. This review summarizes the published evidence from prospective cohort studies examining the associations between vitamin D, measured as serum 25-hydroxyvitamin D (25OHD) concentrations, and the risk of rarer cancer sites including&lt;/p></description></item><item><title>80 percent more likely to have bladder cancer if have low level of vitamin D</title><link>/posts/80-percent-more-likely-to-have-bladder-cancer-if-have-low-level-of-vitamin-d.html</link><pubDate>Tue, 27 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/80-percent-more-likely-to-have-bladder-cancer-if-have-low-level-of-vitamin-d.html</guid><description>&lt;h4 id="plasma-25-hydroxyvitamin-d3-and-bladder-cancer-risk-according-to-tumor-stage-and-fgfr3-status-a-mechanism-based-epidemiological-study">Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study.&lt;/h4>
&lt;p>J Natl Cancer Inst. 2012 Oct 29.&lt;/p>
&lt;p>Amaral AF, Méndez-Pertuz M, Muñoz A, Silverman DT, Allory Y, Kogevinas M, Lloreta J, Rothman N, Carrato A, Rivas Del Fresno M, Real FX, Malats N.&lt;/p>
&lt;p>Affiliations of authors: Genetic and Molecular Epidemiology Group (AFSA, NM) and Epithelial Carcinogenesis Group (MM-P, FXR), Spanish National Cancer Research Centre, Madrid, Spain; Instituto de Investigaciones Biomédicas &amp;ldquo;Alberto Sols,&amp;rdquo; Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain (AM); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (DTS, NR); INSERM, U955, Institut Mondor de Recherche Biomédicale, Créteil, France (YA); Centre for Research in Environmental Epidemiology and Hospital del Mar Research Institute and CIBER Epidemiologia y Salud Pública, Barcelona, Spain (MK); National School of Public Health, Athens, Greece (MK); Departament de Patologia, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain (JL); Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain (JL, FXR); Hospital General Universitario de Elche, Elche, Spain (AC); Hospital Ramon y Cajal, Madrid, Spain (AC); Hospital de Cabueñes, Gijón, Spain (MRF).&lt;/p></description></item><item><title>Cancer - Bladder</title><link>/posts/cancer-bladder.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/cancer-bladder.html</guid><description>&lt;h4 id="bladder-cancer----june-2022">Bladder Cancer – June 2022&lt;/h4>
&lt;p>&lt;strong>A prospective trial investigating the role of Serum 25-Hydroxyvitamin D in diagnosis and prognosis of bladder cancer&lt;/strong>&lt;/p>
&lt;p>PLOS x Published: June 16, 2022 &lt;a href="https://doi.org/10.1371/journal.pone.0266371">https://doi.org/10.1371/journal.pone.0266371&lt;/a>&lt;/p>
&lt;p>Ahmed Abdelgawad ,Abdelwahab Hashem,Ahmed Mosbah ,Laila A. Eissa&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/bladder-cancer-table.jpg" alt="image" width="900">
&lt;p>Purpose&lt;/p>
&lt;p>Higher levels of serum 25-hydroxyvitamin D 25(OHD) are associated with better prognosis in breast and colorectal cancer. However, the evidence is still inconclusive for bladder cancer (BC). Herein, we investigated the diagnosis and prognosis roles of serum levels of 25(OHD) in suspected BC patients presented by hematuria.&lt;/p></description></item><item><title>Bladder Cancer, Vitamin D, and Fibroblast Growth Factor</title><link>/posts/bladder-cancer-vitamin-d-and-fibroblast-growth-factor.html</link><pubDate>Wed, 31 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/bladder-cancer-vitamin-d-and-fibroblast-growth-factor.html</guid><description>&lt;h4 id="plasma-25-hydroxyvitamin-d3-and-bladder-cancer-risk-according-to-tumor-stage-and-fgfr3-status-a-mechanism-based-epidemiological-study">Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study.&lt;/h4>
&lt;p>J Natl Cancer Inst. 2012 Oct 29.&lt;/p>
&lt;p>Amaral AF, Méndez-Pertuz M, Muñoz A, Silverman DT, Allory Y, Kogevinas M, Lloreta J, Rothman N, Carrato A, Rivas Del Fresno M, Real FX, Malats N.&lt;/p>
&lt;p>Affiliations of authors: Genetic and Molecular Epidemiology Group (AFSA, NM) and Epithelial Carcinogenesis Group (MM-P, FXR), Spanish National Cancer Research Centre, Madrid, Spain; Instituto de Investigaciones Biomédicas &amp;ldquo;Alberto Sols,&amp;rdquo; Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain (AM); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (DTS, NR); INSERM, U955, Institut Mondor de Recherche Biomédicale, Créteil, France (YA); Centre for Research in Environmental Epidemiology and Hospital del Mar Research Institute and CIBER Epidemiologia y Salud Pública, Barcelona, Spain (MK); National School of Public Health, Athens, Greece (MK); Departament de Patologia, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain (JL); Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain (JL, FXR); Hospital General Universitario de Elche, Elche, Spain (AC); Hospital Ramon y Cajal, Madrid, Spain (AC); Hospital de Cabueñes, Gijón, Spain (MRF).&lt;/p></description></item></channel></rss>